Gaucher's disease: treatment
Evidence-based neurology checklist on gaucher's disease: treatment: Enzyme replacement therapy (ERT): first line therapy Imiglucerase Velaglucerase alfa Taliglucerase alfa Substrate reduction therapy (SRT): second line therapy Other treatments Investigational treatments
Enzyme replacement therapy (ERT): first line therapy
- Imiglucerase
- Velaglucerase alfa
- Taliglucerase alfa
Substrate reduction therapy (SRT): second line therapy
Other treatments
Investigational treatments
References
- Linari S, Castaman G. Clinical manifestations and management of Gaucher disease. Clin Cases Miner Bone Metab 2015; 12:157-164.
- Dumitrascu DL. Gaucher disease: an update. Med Pharm Rep 2021; 94(Suppl No 1):S54-S56.
- Roshan Lal T, Sidransky E. The spectrum of neurological manifestations associated with Gaucher disease. Diseases 2017; 5:10.
